|Bid||0.0000 x N/A|
|Ask||0.0000 x N/A|
|Day's range||3.4620 - 3.5200|
|52-week range||3.4620 - 3.5200|
|Beta (5Y monthly)||1.52|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Celebrations may be in order for MEI Pharma, Inc. ( NASDAQ:MEIP ) shareholders, with the analysts delivering a...
If you want to know who really controls MEI Pharma, Inc. ( NASDAQ:MEIP ), then you'll have to look at the makeup of its...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into MEI Pharma, Inc. (NasdaqGS: MEIP).